Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia
Ogivri is the first trastuzumab biosimilar approved and launched in Australia and available on the Pharmaceutical Benefits Scheme…
Trivitron and C-Camp sign an MoU
The partnership is a strategic step towards co-development of world-class healthcare technologies completely indigenously under…
Warning letter woes: Dr Reddy’s expects FDA inspection of AP plant by year-end
The company's API plant at Miryalaguda was given an Establishment Inspection Report (EIR) in 2017 resolving the earlier warning…
Sun Pharma Announces Regulatory Filing of Tildrakizumab in Japan
Japan is a key market with approximately 430,000 people currently suffering from psoriasis and psoriatic arthritis
Express Pharma August 01-15, 2019
India's Foremost Pharma & Biotech Magazine ~ Swadeshi Visionary
Indian’s big pharma companies finding new growth opportunities in China: Report
The Chinese pharma market is set to be worth $209 billion by 2022
Indian pharmaceutical companies are finding lucrative…
DBT-BIRAC and AIIMS organise Leadership Dialogue Series
In the second lecture edition of the series, Dr Trevor Mundel, President, Global Health, Bill & Melinda Gates Foundation spoke…
NPPA to hire 12 consultants for different posts
The last date for submitting the application form is August 14, 2019
Newer technology will disrupt the pharma manufacturing process
During the panel discussion experts discusses about New technologies: Challenges in incorporating quality and compliance. It was…
Alembic reports a 37 per cent hike in net profits
The company reported that its net sales shot up by 10 per cent at Rs 949 cr in Q1 while profit before exceptional items and tax…